• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals (NQ: VNDA )

4.660 +0.010 (+0.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 397,341
Open 4.660
Bid (Size) 4.300 (2)
Ask (Size) 4.710 (5)
Prev. Close 4.650
Today's Range 4.620 - 4.710
52wk Range 3.295 - 6.750
Shares Outstanding 55,638,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
November 01, 2024
HC Wainwright initiates Buy on Vanda Pharmaceuticals with an $18 price target, citing undervaluation, a strong product portfolio, and growth in neurology. 
Via Benzinga
Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today
September 19, 2024
A regulator's decision drained the market's enthusiasm for the company. 
Via The Motley Fool

Performance

YTD
+3.10%
+3.10%
1 Month
+3.56%
+3.56%
3 Month
-12.24%
-12.24%
6 Month
-3.72%
-3.72%
1 Year
+3.10%
+3.10%

More News

Read More
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
September 19, 2024
Via Benzinga
Exposures Product Safety
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
Via PressReach
Exposures Product Safety
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
April 17, 2024
Via The Motley Fool
What's Going On With Vanda Pharmaceuticals Shares Today?
June 27, 2024
Via Benzinga
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 20, 2024
Via Benzinga
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 20, 2024
Via Benzinga
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 20, 2024
Via Benzinga
Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday
June 13, 2024
Via Benzinga
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
June 10, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
S&P 500 Edges Lower; J. M. Smucker Shares Surge Following Earnings Beat
June 06, 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
Via Benzinga
Crude Oil Jumps 2%; Lululemon Posts Upbeat Earnings
June 06, 2024
Via Benzinga
Exposures Fossil Fuels
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal
June 06, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 06, 2024
Via InvestorPlace
Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 09, 2024
Via Benzinga
VNDA Stock Earnings: Vanda Pharma Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
Via InvestorPlace
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
April 25, 2024
From Shareholder Capital LLC
Via GlobeNewswire
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
April 22, 2024
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Crude Oil Dips 3%; U.S. Bancorp Profit Tops Views
April 17, 2024
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 17, 2024
Via Benzinga
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
April 17, 2024
Via Benzinga
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 17, 2024
Via Benzinga
Why Is Trio Petroleum (TPET) Stock Down 22% Today?
April 17, 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap